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Abstract
Background: The choice of primary hip hemiarthroplasty or total hip arthroplasty for displaced femoral neck
fracture is still controversial. Revision hip arthroplasty not only increases risk and cost but also could result in
worse outcome. Determining the risk factors for revision can help inform medical decision-making and aid in
risk stratification of publicly reported outcomes. Therefore, we conducted a nationwide population-based study
to identify the disease-related risk factors and construct a risk score nomogram to predict revision surgery.
Methods: Records of all 68,030 femoral neck fracture patients receiving partial hemiarthroplasty (HA) in 2000–2010,
with no total hip arthroplasty (THA) or revision HA history, were collected from the National Health Insurance
Research Database. Cox proportional hazard regression was used to estimate the risk of revision hip replacement
(RHA). The score of each risk factor was the quotient of the regression coefficient of the variable by the regression
coefficient for a 10-year increase in age. The predictive accuracy was tested using the area under the receiver
operating characteristic curve (AUROC).
Results: The revision risk for hemiarthroplasty increased in male, those with schizophrenia and end-stage renal disease
patients had 1.58-, 1.88-, and 1.74-fold revision HA risk (95 % confidence interval (CI) = 1.40–1.78, 1.26–2.79, and 1.29–2.
34, respectively). In a predictive model, the cumulative risk score ranged from 0 to 13 with a 5.08 to 91.82 % 10-year
predicted RHA risk. The percentage of AUROC for 10-year RHA risk in nomogram was 61.9 (95 % CI = 60.0–63.4).
Conclusions: Males, schizophrenia and end-stage renal disease patients have higher risk of revision surgery after
hemiarthroplasty for femoral neck fracture.
Background
With the rapid development of the aging population, the
total number of patients worldwide with hip fracture is
predicted to rise to 6.26 million per year by 2050 [1].
Based on location, femoral neck fractures account for 45
to 53 % of hip fractures. The three major treatments for
femoral neck fractures in clinical practice are internal
fixation, hemiarthroplasty (HA), and total hip arthro-
plasty (THA) [2, 3]. While internal fixation applies to
undisplaced intracapsular fractures [4], the other two
operative methods are advisable for displaced fractures
in the elderly [5]. Since HA is a standardized surgical
method that allows early weight bearing and recovery, it
has become an established procedure with low risk of
postoperative complications. Nonetheless, higher phys-
ical demands, even in older adults, occasionally necessi-
tate conversion surgery to THA; this processes likely to
increase both the possible risks and the associated costs
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[6, 7]. While debate continues on whether primary THA
or HA is best for displaced femoral neck fracture [6, 8–10],
the high complication rate of revision HA in comparison
with THA is clearly known [11].
Therefore, it has become critical to determine the spe-
cific risk factors associated with the conversion of HA to
revision hip replacement (RHA), to better assess the
relative risks of each surgical procedure. The few studies
of the risk factors associated with conversion to THA for
hemiarthroplasty have identified several risk factors, such
as younger age and male gender [12]. However, the weight
of each risk factor has not yet been determined. Thus, we
conducted a population-based, case-control study using
the nationwide population-based database of a universal
insurance program to evaluate the disease-related risk
factors for conversion of HA to THA in femoral neck
fracture in older adults.
Methods
Data source
The Taiwan Bureau of National Health Insurance (TBNHI)
set up a single-payer National Health Insurance (NHI)
Program on March 1, 1995. Almost all residents in Taiwan
join this program. TBNHI commissioned the National
Health Research Institutes to maintain the National Health
Insurance Research Databases (NHIRDs) derived from the
NHI program. We obtained from the NHIRDs data on all
inpatient claims from 1996 to 2011. To be in compliance
with the Personal Information Protection Act, the insur-
ance information was de-identified and the scientists signed
an agreement that they had no intention of obtaining
personal information. This study was approved by the local
institutional review board. The identification of disease was
based on the International Classification of Diseases, Ninth
Revision, Clinical Modification (ICD-9-CM) codes in the
NHIRDs.
Study subjects and end-points
We collected adult patients with a new diagnosis of fem-
oral neck fracture (ICD-9-CM code 820) who received
partial hip arthroplasty (HA, ICD-9-operation code 81.52)
in 2000–2010 (N = 68,755). The date of HA treatment was
defined as the index date. Patients who had received total
hip replacement (ICD-9-operation code 81.51, n = 592) or
RHA (ICD-9-operation code 81.53, n = 133) before the
index date were excluded. All study subjects were followed
from the index date to the date of RHA treatment. Those
without RHA treatment were followed until the date of
withdrawal from the program or the end of 2011.
For the prediction model, we randomly assigned HA
patients to either a derivation group or a validation
group in a 3:1 ratio.
Risk factors
The risk factors included age, gender, and comorbidity.
Comorbidities assessed (using ICD-9-CM codes) included
diabetes (250), osteoporosis (733.0, V17.81, V82.81),
rheumatoid arthritis (RA; 714), cancer (140–208), chronic
obstructive pulmonary disease (COPD; 491,492, 496),
previous osteoarthritis hip (715.5), end-stage renal disease
(ESRD; 585), systemic lupus erythematosus (SLE; 710.0),
ankylosing spondylitis (720), obesity (278.0), extrinsic
asthma (493.0), human immunodeficiency virus (HIV;
042, V08, 795.71), atherosclerosis (440), smoking (350.1
and 649.0), psoriasis (696), viral hepatitis (070), depression
(296.2, 296.3, 296.82, 300.4, 311), schizophrenia (295),
heart failure (428), urinary tract infection (UTI; 599.0),
ischemic heart disease (410–414), dementia (290, 294.1,
and 331.0–331.2), and alcoholism (291, 303, 305.00–
305.03, 790.3, V11.3). All comorbidities were defined
before the index date.
Statistical analysis
Incidence of RHA and RHA-associated risk factors
The incidence of RHA (per 1000 person-years) was
determined in patients by age, gender, and comorbidity.
Cox proportional hazard regression was used to estimate
the hazard ratios (HRs) and 95 % confidence interval
(CI) of RHA and the RHA-associated risk factor. Multi-
variable modeling was used, controlling for significant
factors using crude Cox proportional hazard regression.
Prediction model
In future analysis, the prediction model was developed
according to those risk factors identified as significant in
this study. The score of each risk factor was the quotient
of the regression coefficient of the variable by the regres-
sion coefficient for a 10-year increase in age. The cumu-
lative risk score was the sum of the score of each risk
factor. The area under the receiver operating character-
istic curve (AUROC) of the nomogram was used to test
the association of factors with RHA treatment using
logistic regression. In future analysis, the patients were
grouped into three groups based on risk scores: low (risk
score 0–2), median (risk score 3–4), and high (risk score
5+). We plotted the cumulative incidence among risk
score groups by Kaplan-Meier analysis in derivation and
validation cohort. All statistical analyses were performed
using the SAS software package SAS (version 9.4 for
windows; SAS Institute, Cary, NC).
Results
All 68,030 femoral neck fracture patients who received
hip hemiarthroplasty (HA) were selected for this study.
Most patients were older than 70 years (80.8 %) and the
mean age was 77.3 years (standard deviation = 9.26,
Table 1). Most HA patients were female (65.0 vs. 35.0 %).
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Table 1 Incidence and hazard ratio for revision hip replacement and associated risk factor
n (%) Event no. PY Ratea Crude HR (95 % CI) Adjusted HR (95 % CI)
Total 68,030 1114 238,875 4.66
Age, year
20–29 53 (0.08) 9 260 34.57 30.9 (13.4–71.5)*** 23.6 (10.2–54.7)***
30–39 158 (0.23) 11 832 13.23 12.0 (5.43–26.4)*** 8.52 (3.85–18.9)***
40–49 499 (0.73) 25 2302 10.86 9.49 (4.93–18.3)*** 6.90 (3.56–13.4)***
50–59 1862 (2.74) 63 7908 7.97 6.65–3.73 (11.9)*** 5.48 (3.06–9.82)***
60–69 10,492 (15.4) 257 45,526 5.65 4.77 (2.79–8.17)*** 4.35 (2.54–7.46)***
70–79 26,868 (39.5) 458 101,757 4.50 3.59 (2.11–6.12)*** 3.38 (1.99–5.76)***
80–89 24,095 (35.4) 277 71,159 3.89 2.80 (1.64–4.80)*** 2.73 (1.60–4.68)***
≥90 4003 (5.88) 14 9132 1.53 1.00 1.00
Mean (SD) 77.3 (9.26)
Gender
Women 44,241 (65.0) 614 163,685 3.75 1.00 1.00
Men 23,789 (35.0) 500 75,190 6.65 1.69 (1.50–1.90)*** 1.58 (1.40-1.78)***
Comorbidity
Diabetes
No 51,877 (76.3) 861 191,518 4.50 1.00
Yes 16,153 (23.7) 253 47,357 5.34 1.09 (0.95–1.26)
Osteoporosis
No 64,702 (95.1) 1057 228,211 4.63 1.00
Yes 3328 (4.89) 57 10,664 5.35 1.11 (0.85–1.45)
RA
No 67,472 (99.2) 1099 236,796 4.64 1.00
Yes 558 (0.82) 15 2079 7.21 1.57 (0.94–2.61)
Cancer
No 62,848 (92.4) 1038 226,145 4.59 1.00
Yes 5182 (7.62) 76 12,730 5.97 1.14 (0.90–1.44)
COPD
No 60,853 (89.4) 1008 219,410 4.59 1.00
Yes 7177 (10.6) 106 19,465 5.45 1.07 (0.88–1.31)
ESRD
No 66,073 (97.1) 1068 234,698 4.55 1.00 1.00
Yes 1957 (2.88) 46 4177 11.01 1.99 (1.48–2.68)*** 1.74 (1.29–2.34)***
SLE
No 67,963 (99.9) 1112 238,679 4.66 1.00
Yes 67 (0.10) 2 196 10.19 2.03 (0.51–8.14)
Ankylosing spondylitis
No 64,346 (94.6) 1059 228,091 4.64 1.00
Yes 3684 (5.42) 55 10,785 5.10 1.02 (0.78–1.34)
Extrinsic asthma
No 67,850 (99.7) 1112 238,299 4.67 1.00
Yes 180 (0.26) 2 576 3.47 0.72 (0.18–2.89)
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The 10 most prevalent comorbidities in HA patients were
diabetes (23.7 %), ischemic heart disease (18.2 %), UTI
(17.9 %), COPD (10.6 %), heart failure (8.13 %), cancer
(7.62 %), ankylosing spondylitis (5.42 %), osteoporosis
(4.89 %), dementia (3.52 %), and ESRD (2.88 %).
After a cumulative 12-years follow-up, 1114 patients
received RHA treatment, with an incidence of 4.66 per
1000 person-years (Table 1). In multivariable Cox propor-
tional hazard regression, the RHA risk decreased with
aging from 23.6 to 2.73 in those aged 20-29 to 80-89 years,
respectively, compared with those aged ≥90 years (95 % CI
= 10.2-54.7 and 1.60-4.68, respectively). Compared with
women, men had a significantly higher RHA risk (HR =
1.58, 95 % CI = 1.40–1.78). RHA-associated risk factors for
the total cohort were schizophrenia (HR = 1.88, 95 % CI =
1.26–2.79) and ESRD (HR= 1.74, 95 % CI = 1.29–2.34).
Table 2 presents the distribution between derivation
(75.0 %) and validation (25.0 %) cohort. There was no
significant difference of age, gender, ESRD and schizo-
phrenia between two groups. In derivation cohort, the
risk score decreased one point with every 10 years of age
increasing; for example, the risk score was 7 for patients
aged 20–29 years, 6 for those 30–39 years, 5 for those
40–49 years, and so on (Table 3). The risk score was 2
for men, those with ESRD and schizophrenia patients.
The percentage of AUROC for 10-year RHA risk in
nomogram was 61.9 (95 % CI = 60.0–63.4). In the
prediction model, the cumulative risk score ranged from
Table 1 Incidence and hazard ratio for revision hip replacement and associated risk factor (Continued)
HIV
No 68,022 (99.9) 1114 238,853 4.66 1.00
Yes 8 (0.01) 0 22 0.00 ––
Atherosclerosis
No 67,550 (99.3) 1106 237,521 4.66 1.00
Yes 480 (0.71) 8 1355 5.91 1.17 (0.58–2.35)
Psoriasis
No 67,898 (99.8) 1112 238,505 4.66 1.00
Yes 132 (0.19) 2 370 5.40 1.09 (0.27–4.36)
Viral hepatitis
No 66,212 (97.3) 1080 234,523 4.61 1.00 1.00
Yes 1818 (2.67) 34 4353 7.81 1.46 (1.04–2.06)* 1.30 (0.92–1.83)
Depression
No 66,091 (97.2) 1081 232,874 4.64 1.00
Yes 1939 (2.85) 33 6002 5.50 1.12 (0.79–1.59)
Schizophrenia
No 67,399 (99.1) 1088 236,468 4.60 1.00 1.00
Yes 631 (0.93) 26 2408 10.80 2.43 (1.65–3.58)*** 1.88 (1.26–2.79)**
Heart failure
No 62,500 (91.9) 1035 22,478 4.59 1.00
Yes 5530 (8.13) 79 13,397 5.90 1.11 (0.89–1.40)
UTI
No 55,877 (82.1) 936 204,007 4.59 1.00
Yes 12,153 (17.9) 178 34,869 5.10 1.2 (0.87–1.19)
Ischemic heart disease
No 55,681 (81.9) 915 203,038 4.51 1.00
Yes 12,349 (81.9) 199 35,837 5.55 1.13 (0.97–1.32)
Dementia
No 65,633 (96.5) 1091 231,906 4.70 1.00 1.00
Yes 2397 (3.52) 23 6969 3.30 0.65 (0.43–0.98)* 0.71 (0.47–1.07)
PY person-years, HR hazard ratio, CI confidence interval, SD standard deviation, RA rheumatoid arthritis, COPD chronic obstructive pulmonary disease,
ESRD end-stage renal disease, SLE systemic lupus erythematosus, HIV human immunodeficiency virus, UTI urinary tract infection
*p < 0.05; **p < 0.01; ***p < 0.001
aPer 1000 person-years
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0 to 13 with a 5.08 to 91.82 %10-year predicted RHA
risk (Fig. 1).
Figure 2 presents cumulative incidence of RHA in
different risk score groups. In derivation cohort, the
cumulative incidences of RHA were 2.03, 3.85, and
6.06 % in low, median, and high after 10 years follow-up,
respectively. In validation cohort, patients with higher
risk score had highest cumulative incidence of RHA
(6.24 %) and followed by median and low group (3.86
and 1.85 %).
Discussion
The current study revealed that the rate of RHA for
primary HA for femoral neck fracture is 4.67 per 1000
person-years. Several risk factors, such as age, gender,
ESRD, and schizophrenia, were identified. We also
assessed the contribution of each factor to help clini-
cians predict future revision rate.
Traditionally, surgeons have preferred HA over THA
because of concerns about the increased risk of compli-
cations of the more complex THA. However, more
current data has showed no significant differences in the
complication rates of patients undergoing HA versus
THA [2, 9, 13, 14]. Moreover, the literature shows a
lower risk of reoperation after THA compared with HA
[6, 12, 14–16] and better functional outcomes for
patients after THA versus HA [6, 8–10, 13, 14, 16, 17].










n % n % Chi-square p value
Age, year 0.98
20–29 40 0.08 13 0.08
30–39 113 0.22 45 0.26
40–49 371 0.73 128 0.75
50–59 1388 2.72 474 2.79
60–69 7878 15.4 2614 15.4
70–79 20,177 39.6 6691 39.3
80–89 18,047 35.4 6048 35.6
≥ 90 3007 5.89 996 5.86
Gender 0.97
Women 33,182 65.0 11,059 65.0
Men 17,839 35.0 5959 35.0
Comorbidity
ESRD 1493 2.93 464 2.73 0.18
Schizophrenia 455 0.89 176 1.03 0.09
ESRD end-stage renal disease
Table 3 Incidence and hazard ratio for revision hip replacement
and associated risk factor in derivation cohort





20–29 40.4 (16.0–10.2) 3.700 < 0.0001 7
30–39 12.3 (4.85–31.0) 2.506 < 0.0001 6
40–49 8.40 (3.76–18.8) 2.128 < 0.0001 5
50–59 6.44 (3.14–12.2) 1.862 < 0.0001 4
60–69 4.92 (2.52–9.62) 1.593 < 0.0001 3
70–79 3.97 (2.05–7.71) 1.380 < 0.0001 2
80–89 3.38 (1.74–6.59) 1.218 0.0003 1
≥ 90 Ref. 0 0
Gender
Women Ref. 0 0
Men 1.57 (1.36–1.80) 0.449 < 0.0001 2
ESRD
No Ref. 0 0
Yes 1.72 (1.22–2.43) 0.542 0.002 2
Schizophrenia
No Ref. 0 0








HR hazard ratio, CI confidence interval, AUROC the area under the receiver
operating characteristic curve
Fig. 1 Nomograms for the prediction of the RHA risk
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HA comes with considerable risk of reoperation with
conversion to THA [18, 19]. Finite element mode study
has proven that HA increases the biomechanical stresses
on the acetabular bone that would result in migration of
the head and destruction of the acetabulum [20]. Several
studies found significant acetabular wear in up to 67 %
of cases [21, 22], quantified at an average rate of 0.7 mm
per year [22]. The inability to restore the femoral offset
is also a factor [23], impairing the ability to balance
tissue tension. However, THA is not suitable for every
patient, including those with multiple morbidities or those
with limited life expectancy [24]. The disadvantages of
THA include greater blood loss and higher costs compared
with HA [13]. Despite higher initial costs, the overall costs
of THA are lower.
Young age and male gender are well-identified risk
factors for revision HA surgery [12], but no literature
has described schizophrenia or ESRD as risk factors for
revision HA surgery. Schizophrenia has been associated
with higher odds of perioperative blood transfusion,
adverse events, and non-routine discharge following
total joint arthroplasty (TJA) [25, 26] or spine surgery
[27]. ESRD is also a risk factor for perioperative allogen-
eic blood transfusions [28], as it increased both mortality
and the complication rate in TJR [29, 30].
Risk equations and risk functions have been widely
applied for patient counseling, clinical diagnosis, risk
stratification, treatment selection, and prognosis predic-
tion; these have especially been useful in medical fields
such as cardiovascular disease [31], hepatic disease
[32, 33], and cancer [34, 35]. Most risk score systems
used in orthopedic surgery are constructed according
to the preoperative damage condition [36, 37], bony
destruction [38], or postoperative fixation status [39].
In preoperative assessment of displaced femoral neck
fracture without complicated bony destruction, using
demographic data and underlying comorbidity is an easy
way to predict risk of revision. The nomogram of this
study does not require complex calculations but allows
surgeons to estimate the impact of demographic risk
factors by easily adding the risk score. It helps facilitate
clinician communication with patients about risk predic-
tion and decision-making.
Our study has several limitations. First, we relied on
NHIRDs to identify revisions and risk factors for revision
HA surgery. Because the ICD-9 coding is representative of
diseases, but not of the life style neither the physical
finding. We are not able to analyze the population of
smoker, alcohol use, and obesity because the insurance
system only could code when the patients ask for medical
treatment, which means the life style has threaten the
health. Therefore, our data cannot show the risk of RHA
in smoker, alcohol use, either BMI for obesity. However,
smoke is a risk factor to infection [40], early failure, and
revision surgery in total hip arthroplasty. Dislocation risk
will be increased in alcoholism after total hip arthroplasty
[41].
Second, the most common cause of revision hip
replacement is loosening of the prosthesis (Table 4);
however, there is no coding about primary surgery method
or revision method. Therefore, we were not able to assess
the surgical approach and type of prosthesis used (includ-
ing retained stem, cemented, or noncemented prosthesis).
Surgical approach would play a role in dislocation rate
after hemiarthroplasty. Direct anterior [42, 43] or anterior-
lateral approach has less dislocation rate that posterior
approach [44, 45]. Both cemented and uncemented stem
have good functional results in hip hemiarthroplasty for
displaced femoral neck fractures [46]. But the uncemen-
ted hemiarthroplasty has high risk of postoperative
Fig. 2 Cumulative incidence for revision hip replacement among different risk score groups: low (risk score 0–2), median (risk score 3–4),
and high (risk score 5+) in derivation (a) and validation (b) cohort
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periprosthetic femoral fractures to reoperation [47–50].
However, previous investigators have reported a reason-
able correlation between administrative claims and the
clinical record when evaluating causes and types of
revision TJA procedures [13]. Third, our study was a
retrospective cohort study rather than a prospective
randomized trial. Besides, the life style pattern and phys-
ical characters of people vary in different countries. The
medical insurance data result may be not as the same as
other country due to different socioeconomic situations
between nations. There may be some risk factors not
significant in one population but may play an important
role in others due to risk exposure cases number, espe-
cially in life style. Our result would not be representative
of other country or population. However, the use of a
population-based data set allows for the enrollment of a
large number of patients and is highly representative of
the risk factors of diseases found in a general population.
This study reveals the importance of associated diseases
affect the outcome in hip hemiarthroplasty for femoral
neck fracture. In the future, we still need more cases form
other population for comparison and meta-analysis to find
out more risk factor or related disease.
Finally, our results are limited to risk factors for fail-
ures that occur within the 10 years after primary HA,
and therefore, it is unclear whether the same or other
risk factors are associated with longer term follow-up.
However, the impact of patient comorbidities on the risk
of revision after HA has important clinical and policy
implications for the health care system. Finally, these
HAs were for femoral neck fracture only; our study does
not address the risk factors for HA for osteonecrosis of
the femoral head.
Conclusions
In conclusion, to assess the future risk of revision, a risk
score system was developed, based on patient demo-
graphics and comorbidities. Although the permissible
degree of postoperative activity depends entirely on the
general health status of each patient, the current result
scan help with arranging earlier rehabilitation and devel-
oping an appropriate follow-up program to prevent early
complications.
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